We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
+5.7%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+359.15%
AUM
$36.9B
AUM Growth
+$1.94B
Cap. Flow
+$154M
Cap. Flow %
0.42%
Top 10 Hldgs %
4.62%
Holding
3,025
New
132
Increased
1,201
Reduced
1,478
Closed
188

Top Buys

Rank Stock Value
1
IDXX icon
Idexx Laboratories
IDXX
+$57.1M
2
INCY icon
Incyte
INCY
+$53M
3
SD icon
SandRidge Energy
SD
+$46.7M
4
SNPS icon
Synopsys
SNPS
+$46.3M
5
AMD icon
Advanced Micro Devices
AMD
+$41.3M

Sector Composition

Rank Sector Weight
1 Technology 13.19%
2 Financials 13.13%
3 Healthcare 11.29%
4 Industrials 11.08%
5 Consumer Discretionary 10.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GEF.B icon
2801
Greif Class B
GEF.B
$4.11B
$12K ﹤0.01%
190
-9
-5% -$606
VERU icon
2802
Veru
VERU
$36M
$12K ﹤0.01%
1,198
+7
+0.6% +$72
AVEO
2803
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$12K ﹤0.01%
2,050
+205
+11% +$1.48K
ESNC
2804
DELISTED
EnSync Inc
ESNC
$12K ﹤0.01%
20,130
+120
+0.6% +$75
AUMN
2805
DELISTED
Golden Minerals Company
AUMN
$11K ﹤0.01%
707
+4
+0.6% +$65
TMBR
2806
DELISTED
Timber Pharmaceuticals, Inc.
TMBR
$11K ﹤0.01%
+2
New +$13.8K
TST
2807
DELISTED
TheStreet, Inc.
TST
$11K ﹤0.01%
1,470
+299
+26% +$2.42K
UQM
2808
DELISTED
UQM Technologies, Inc.
UQM
$11K ﹤0.01%
22,966
+137
+0.6% +$64
GLF
2809
DELISTED
GulfMark Offshore, Inc. Common Stock
GLF
$11K ﹤0.01%
29,609
-3,991
-12% -$4.59K
TOVX icon
2810
Theriva Biologics
TOVX
$9.64M
$10K ﹤0.01%
2
IMI
2811
DELISTED
Intermolecular, Inc.
IMI
$10K ﹤0.01%
+10,806
New +$11.3K
CRVP
2812
DELISTED
Crystal Rock Holdings, Inc.
CRVP
$10K ﹤0.01%
11,469
+68
+0.6% +$54
SSKN
2813
DELISTED
Strata Skin Sciences
SSKN
$9K ﹤0.01%
305
+2
+0.7% +$57
GMO
2814
DELISTED
General Moly, Inc.
GMO
$9K ﹤0.01%
+18,108
New +$8.71K
OGEN icon
2815
Oragenics
OGEN
$2.26M
$8K ﹤0.01%
1
SLS icon
2816
SELLAS Life Sciences
SLS
$1.97B
$8K ﹤0.01%
+9
New +$14.9K
CRTN
2817
DELISTED
Cartesian, Inc.
CRTN
$8K ﹤0.01%
10,085
+60
+0.6% +$67
ACHV icon
2818
Achieve Life Sciences
ACHV
$659M
$7K ﹤0.01%
7
+2
+40% +$2.43K
BATRA icon
2819
Atlanta Braves Holdings Series A
BATRA
$3.49B
$7K ﹤0.01%
305
-5,866
-95% -$125K
CIE
2820
DELISTED
Cobalt International Energy, Inc
CIE
$7K ﹤0.01%
906
-43
-5% -$520
AIM
2821
AIM ImmunoTech
AIM
$7.03M
$7K ﹤0.01%
+3
New +$7.67K
HEDJ icon
2822
WisdomTree Europe Hedged Equity Fund
HEDJ
$1.83B
$6K ﹤0.01%
176
-2,912
-94% -$86.7K
SVRA icon
2823
Savara
SVRA
$1.12B
$6K ﹤0.01%
666
+4
+0.6% +$35
TRNX
2824
DELISTED
Taronis Technologies, Inc. Common Stock
TRNX
$6K ﹤0.01%
+1
New +$7.36K
ANTH
2825
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
$6K ﹤0.01%
+1,893
New +$8.95K

Similar funds

Guggenheim Capital's Q1 2017 Portfolio in Review

As of Q1 2017, Guggenheim Capital held 3,025 positions worth $36.9B, up 5.5% from $35B the previous quarter. Its ten largest holdings account for 4.6% of the portfolio.

Guggenheim Capital's Q1 2017 filing shows 132 new, 1,201 increased, 1,478 reduced and 188 closed positions. Its largest new stake was Guggenheim Taxable Municipal Bond & Investment Grade Debt Trust: 1,177,888 shares worth $26.2M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $92.1M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.

  • Guggenheim Capital's largest Q1 2017 buy was Guggenheim Taxable Municipal Bond & Investment Grade Debt Trust: 1,177,888 shares worth $26.2M.
  • Guggenheim Capital added most to Idexx Laboratories in Q1 2017, an estimated $57.1M increase.
  • Guggenheim Capital's biggest Q1 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $92.1M.
  • Guggenheim Capital fully exited Linear Technology Corp in Q1 2017, selling an estimated $72.6M.
  • Guggenheim Capital's ten largest holdings make up 4.6% of its $36.9B portfolio in Q1 2017.
  • Guggenheim Capital opened 132 new positions and closed 188 in Q1 2017.
  • Guggenheim Capital's portfolio value rose 5.5% quarter-over-quarter to $36.9B.

Based on Guggenheim Capital's 13F filing for Q1 2017, filed 15 May 2017.